| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.5B | $5.6B | $5.4B | $4.9B | $1.1B | $1.0B | $1.1B | $1.1B |
| Cost of Revenue | $1.0B | $3.7B | $3.5B | $3.5B | $0.8B | $0.8B | $0.8B | $0.8B |
| Gross Profit | $0.5B | $1.9B | $1.9B | $1.5B | $0.3B | $0.3B | $0.3B | $0.3B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.2B | $0.8B | $0.8B | $0.8B | $0.2B | $0.2B | $0.2B | $0.2B |
| Operating Income | $1.2B | $1.1B | $1.0B | $0.7B | $0.5B | $0.5B | $0.6B | $0.6B |
| Net Income | $0.2B | $0.8B | $0.8B | $0.5B | $0.4B | $0.1B | $0.1B | $0.1B |
| EPS (Basic) | $4.21 | $14.46 | $14.14 | $10.13 | $2.15 | $1.49 | $1.87 | $1.61 |
| EPS (Diluted) | $4.19 | $14.37 | $14.05 | $10.07 | $2.14 | $1.48 | $1.85 | $1.60 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $8.2B | $6.7B | $6.9B | $5.4B | $5.3B | $5.1B | $4.9B | $4.9B |
| Current Assets | $2.6B | $2.1B | $2.2B | $2.0B | $1.9B | $1.6B | $1.6B | $1.6B |
| Cash & Equivalents | $0.5B | $0.3B | $0.3B | $0.4B | $0.3B | $0.3B | $0.2B | $0.2B |
| Total Liabilities | $4.4B | $3.4B | $4.0B | $3.0B | $3.0B | $3.0B | $2.9B | $3.1B |
| Current Liabilities | $1.5B | $1.3B | $1.3B | $1.1B | $1.1B | $0.9B | $0.8B | $0.8B |
| Stockholders' Equity | $3.8B | $3.3B | $2.9B | $2.4B | $2.2B | $2.1B | $1.9B | $1.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.0B | — | — | — | — | $0.6B | $0.6B | $0.5B |
| Investing Cash Flow | $-1.1B | — | — | — | — | $-0.3B | $-0.1B | $-1.2B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $0.2B | $-0.9B | $0.4B | $-0.4B | $-0.4B | $-0.2B | $-0.5B | $0.5B |